15 Dec Date December 15, 2021 Categories Medregen Phase II COVID-19 ARDS Trial Initiated A multi-center international trial studying the immunoregulatory and regenerative potential of MRG-001 in severe and critically ill COVID-19 patients has been initiated by MedRegen.